DiaMedica Therapeutics Inc.
DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, develops treatments for neurological and kidney diseases. The company's lead drug candidate is DM199, a recombinant human tissue kallikrein-1 protein, which is in Phase 2 REDUX tria…
Biotechnology
US, Minneapolis [HQ]
Strategy & Leadership
Mergers & Acquisitions Beta
M&As
M&A Deals · Breakdown
DiaMedica Therapeutics Inc. has no acquisition track records yet.
M&A Deals · History
DiaMedica Therapeutics Inc. has no acquisition track records yet.